High Serum Levels of Serum 100 Beta Protein, Neuron-specific Enolase, Tau, Active Caspase-3, M30 and M65 in Children with Autism Spectrum Disorders

키워드

참고문헌 (54)

1. Rossignol DA, "A review of research trends in physiological abnormalities in autism spectrum disorders : immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures", Mol Psychiatry, 17, pp.389~401 (2012)
2. Khramova TV, "Serologic markers of autism spectrum disorder", J Mol Neurosci, 62, pp.420~429 (2017)
3. Masi A, "The immune system, cytokines, and biomarkers in autism spectrum disorder", Neurosci Bull, 33, pp.194~204 (2017)
4. Watanabe A, "In vivo phosphorylation sites in fetal and adult rat tau", J Biol Chem, 268, pp.25712~25717 (1993)
5. de la Monte SM, "Brain insulin resistance and deficiency as therapeutic targets in Alzheimer’s disease", Curr Alzheimer Res, 9, pp.35~66 (2012)
6. Johnson GV, "Tau phosphorylation in neuronal cell function and dysfunction", J Cell Sci, 117(Pt 24), pp.5721~5729 (2004)
7. Shaw GJ, "Serum cleaved tau protein levels and clinical outcome in adult patients with closed head injury", Ann Emerg Med, 39, pp.254~257 (2002)
8. Shipton OA, "Tau protein is required for amyloid {beta}-induced impairment of hippocampal long-term potentiation", J Neurosci, 31, pp.1688~1692 (2011)
9. Parellada M, "The neurobiology of autism spectrum disorders", Eur Psychiatry, 29, pp.11~19 (2014)
10. Sheikh AM, "Cathepsin D and apoptosis related proteins are elevated in the brain of autistic subjects", Neuroscience, 165, pp.363~370 (2010)
11. Barón-Mendoza I, "Alterations in neuronal cytoskeletal and astrocytic proteins content in the brain of the autistic-like mouse strain C58", J, 2018, pp.682, 32~38
12. Kadak MT, "Low serum level α-synuclein and tau protein in autism spectrum disorder compared to controls", Neuropediatrics, 46, pp.410~415 (2015)
13. Chang Q, "Role of microtubule-associated protein in autism spectrum disorder", Neurosci Bull, 34, pp.1119~1126 (2018)
14. Baudier J, "Interactions between the microtubule-associated tau proteins and S100b regulate tau phosphorylation by the Ca2＋", calmodulin-dependent protein kinase II, 1988, pp.263, 5876~5883
15. Shirasaki Y, "Serum S-100b protein as a biomarker for the assessment of neuroprotectants", Brain Res, 1021, pp.159~166 (2004)
16. Wunderlich MT, "Head injury outcome prediction in the emergency department: a role for protein S-100B?", J Neurol Neurosurg Psychiatry, 74, pp.827~828 (2003)
17. Van Eldik LJ, "Neurotrophic activity of S-100 beta in cultures of dorsal root ganglia from embryonic chick and fetal rat", Brain Res, 542, pp.280~285 (1991)
18. Bhattacharyya A, "S100 is present in developing chicken neurons and Schwann cells and promotes motor neuron survival in vivo", J Neurobiol, 23, pp.451~466 (1992)
19. Michetti F, "The S100B protein in biological fluids : more than a lifelong biomarker of brain distress", J Neurochem, 120, pp.644~659 (2012)
20. Zhang XY, "Increased serum S100B in never-medicated and medicated schizophrenic patients", J Psychiatr Res, 44, pp.1236~1240 (2010)
21. Schroeter ML, "Serum S100B represents a new biomarker for mood disorders", Curr Drug Targets, 14, pp.1237~1248 (2013)
22. Al-Ayadhi LY, "A lack of association between elevated serum levels of S100B protein and autoimmunity in autistic children", J Neuroinflammation, 9, pp.54~ (2012)
23. Shaker NM, "Serum levels of S100b, interleukin-6 and anti-transglutaminase Ii IgA as immune markers in a sample of Egyptian children with autistic spectrum disorders", Autism Open Access, 6, pp.1000191~ (2016)
24. Guloksuz SA, "Elevated plasma concentrations of S100calcium-binding protein B and tumor necrosis factor alpha in children with autism spectrum disorders", Rev Bras Psiquiatr, 39, pp.195~200 (2017)
25. Heshmati HM, "Serum neuron-specific enolase in patients with pituitary adenoma", Clin Chem, 43, pp.540~541 (1997)
26. Royds JA, "Enolase isoenzymes in the cerebrospinal fluid of patients with diseases of the nervous system", J Neurol Neurosurg Psychiatry, 46, pp.1031~1036 (1983)
27. Johnsson P, "Neuron-specific enolase increases in plasma during and immediately after extracorporeal circulation", Ann Thorac Surg, 69, pp.750~754 (2000)
28. 송태진, "Serum and Cerebrospinal Fluid Neuron-Specific Enolase for Diagnosis of Tuberculous Meningitis", Yonsei Medical Journal, 53(6), pp.1068~1072 (2012), 연세대학교의과대학[DOI]
29. Wang Y, "Hypermethylation of the enolase gene(ENO2)in autism", Eur J Pediatr, 173, pp.1233~1244 (2014)
30. Lv MN, "The neonatal levels of TSB, NSE and CK-BB in autism spectrum disorder from Southern China", Transl Neurosci, 7, pp.6~11 (2016)
31. Bantel H, "Detection of elevated caspase activation and early apoptosis in liver diseases", Eur J Cell Biol, 80, pp.230~239 (2001)
32. Woolbright BL, "Cell death and prognosis of mortality in alcoholic hepatitis patients using plasma keratin-18", Gene Expr, 17, pp.301~312 (2017)
33. Thompson CB, "Apoptosis in the pathogenesis and treatment of disease", Science, 267, pp.1456~1462 (1995)
34. Afford S, "Apoptosis", Mol Pathol, 53, pp.55~63 (2000)
35. Sheikh AM, "BDNF-Akt-Bcl2 antiapoptotic signaling pathway is compromised in the brain of autistic subjects", J Neurosci Res, 88, pp.2641~2647 (2010)
36. Malik M, "Expression of inflammatory cytokines, Bcl2 and cathepsin D are altered in lymphoblasts of autistic subjects", Immunobiology, 216, pp.80~85 (2011)
37. Wei H, "The apoptotic perspective of autism", Int J Dev Neurosci, 36, pp.13~18 (2014)
38. American Psychiatric Association, "DSM-5 Task Force. Diagnostic and statistical manual of mental disorders: DSM-5" (2013), American Psychiatric Association
39. İncekaş Gassaloğlu S, "Validity and reliability analysis of Turkish version of childhood autism rating scale", Turk Psikiyatri Derg, 27, pp.266~274 (2016)
40. Schopler E, "Toward objective classification of childhood autism : Childhood Autism Rating Scale(CARS)", J Autism Dev Disord, 10, pp.91~103 (1980)
41. Di Battista AP, "Blood biomarkers in moderate-to-severe traumatic brain injury : potential utility of a multi-marker approach in characterizing outcome", Front Neurol, 6, pp.110~ (2015)
42. Egger G, "Identification of risk genes for autism spectrum disorder through copy number variation analysis in Austrian families", Neurogenetics, 15, pp.117~127 (2014)
43. Han Y, "Abnormal transsulfuration metabolism and reduced antioxidant capacity in Chinese children with autism spectrum disorders", Int J Dev Neurosci, 46, pp.27~32 (2015)
44. Zoroglu SS, "Increased oxidative stress and altered activities of erythrocyte free radical scavenging enzymes in autism", Eur Arch Psychiatry Clin Neurosci, 254, pp.143~147 (2004)
45. Altun H, "Assessment of malondialdehyde levels, superoxide dismutase, and catalase activity in children with autism spectrum disorders", Psychiatr Clin Psychopharmacol, 28, pp.408~415 (2018)
46. Donato R, "S100B’s double life : intracellular regulator and extracellular signal", Biochim Biophys Acta, 1793, pp.1008~1022 (2009)
47. Kawata K, "Blood biomarkers for brain injury: what are we measuring?", Neurosci Biobehav Rev, 68, pp.460~473 (2016)
48. Esposito G, "S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells", J Cell Mol Med, 12, pp.914~927 (2008)
49. Taylor CB, "Diagnostic aspects of enolase isozymes", Isozymes Curr Top Biol Med Res, 11, pp.95~119 (1983)
50. Boatright KM, "Mechanisms of caspase activation", Curr Opin Cell Biol, 15, pp.725~731 (2003)
51. Fatemi SH, "Reduction in anti-apoptotic protein Bcl-2 in autistic cerebellum", Neuroreport, 12, pp.929~933 (2001)
52. Fatemi SH, "Dysregulation of Reelin and Bcl-2 proteins in autistic cerebellum", J Autism Dev Disord, 31, pp.529~535 (2001)
53. Araghi-Niknam M, "Levels of Bcl-2 and P53 are altered in superior frontal and cerebellar cortices of autistic subjects", Cell Mol Neurobiol, 23, pp.945~952 (2003)
54. El-Ansary AK, "Proinflammatory and proapoptotic markers in relation to mono and di-cations in plasma of autistic patients from Saudi Arabia", J Neuroinflammation, 8, pp.142~ (2011)

관련 논문AI추천